IO Biotech, Inc. (IOBT) - Quarterly Income Statement

Home
IOBT
Financials

1.95 (USD) • At close September 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0.85	0	0	0	1.11	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.234	0.227	0.425	0.205	0.214	0.211	0.201	0.194	0.187	0.174	0.19	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.234	-0.227	0.425	-0.205	-0.214	-0.211	0.909	-0.194	-0.187	-0.174	-0.19	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.5	0	0	0	0.819	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	16.652	16.375	21.147	20.178	15.848	14.311	21.77	17.655	16.504	11.9	14.433	10.022	12.226	10.306	16.44	4.128	6.735	2.848	2.21	2.777	1.738	1.738
General & Administrative Expenses Numbers are in millions	6.518	6.209	5.796	6.326	5.685	5.886	6.413	5.829	5.348	6.024	5.955	5.843	5.935	6.704	4.955	2.914	2.248	0.965	0.329	0.654	0.35	0.35
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	-0.201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	6.518	6.209	5.796	6.326	5.685	5.886	6.212	5.829	5.348	6.024	5.955	5.843	5.935	6.704	4.955	2.914	2.248	0.965	0.329	0.654	0.35	0.35
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	23.17	22.584	26.943	26.504	21.533	20.197	27.982	23.484	21.852	17.924	20.388	15.865	18.161	17.01	21.395	7.042	8.983	3.813	2.539	3.431	2.996	2.996
Operating Income Numbers are in millions	-23.17	-22.584	-26.943	-26.504	-21.533	-20.197	-28.183	-23.484	-21.852	-17.924	-20.388	-15.865	-18.161	-17.01	-21.395	-7.042	-8.983	-3.813	-2.539	-3.431	-2.088	-2.088
Operating Income Ratio Numbers are in millions	0	0	-31.698	0	0	0	-25.39	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	-2.929	0.309	-3.945	2.698	1.221	1.155	2.354	1.366	1.206	1.286	1.305	0.292	-0.23	-0.128	0.154	2.58	-29.376	0.065	-0.015	-0.057	-0.913	-0.913
Income Before Tax Numbers are in millions	-26.099	-22.275	-30.888	-23.806	-20.312	-19.042	-25.829	-22.118	-20.646	-16.638	-19.085	-15.573	-18.391	-17.138	-21.241	-4.462	-38.359	-3.748	-2.554	-3.488	-3	-3
Income Before Tax Ratio Numbers are in millions	0	0	-36.339	0	0	0	-23.269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0.118	0.146	0.445	0.209	0.374	0.415	0.353	-0.439	0.532	0.406	0.987	0.115	0.104	0.066	0.068	0	0.071	0	0.011	0.007	0	0
Net Income Numbers are in millions	-26.217	-22.421	-31.333	-24.015	-20.686	-19.457	-26.182	-21.679	-21.178	-17.044	-20.072	-15.688	-18.495	-17.204	-21.309	-4.462	-38.359	-3.748	-2.554	-3.488	-3.511	-3.511
Net Income Ratio Numbers are in millions	0	0	-36.862	0	0	0	-23.587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.4	-0.34	-0.48	-0.36	-0.31	-0.3	-0.4	-0.43	-0.73	-0.59	-0.7	-0.54	-0.64	-0.6	-0.83	-0.17	-3.32	-0.32	-0.22	-0.3	-19.83	-19.83
EPS Diluted Numbers are in millions	-0.4	-0.34	-0.48	-0.36	-0.31	-0.3	-0.4	-0.43	-0.73	-0.59	-0.7	-0.54	-0.64	-0.6	-0.83	-0.17	-3.32	-0.32	-0.22	-0.3	-19.81	-19.81
EBITDA Numbers are in millions	-25.612	-22.584	-26.724	-26.299	-21.319	-19.986	-25.628	-21.924	-21.665	-17.75	-18.894	-15.376	-18.289	-16.795	-21.09	-4.395	-38.287	0	0	0	0	0
EBITDA Ratio Numbers are in millions	0	0	-31.44	0	0	0	-23.088	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

IO Biotech, Inc.

NASDAQ:IOBT Add to watchlist

NASDAQ:IOBT